Combination of histone deacetylase inhibitors and radiation

Details for Australian Patent Application No. 2006306240 (hide)

Owner Novartis AG

Inventors Versace, Richard William

Agent Davies Collison Cave

Pub. Number AU-A-2006306240

PCT Pub. Number WO2007/050655

Priority 60/729,783 24.10.05 US

Filing date 23 October 2006

Wipo publication date 3 May 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050655 Priority application(s): WO2007/050655

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306241-Dietary fiber formulation and method of administration

2006306236-Selective VPAC2 receptor peptide agonists